16.20

0.43% -0.07

After Hours: 16.52 0.32 +1.98%

Cogent Biosciences Inc (COGT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cogent Biosciences Inc stock is traded at $16.20, with a volume of 2.34M. It is down -0.43% in the last 24 hours and up +27.96% over the past month. Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Previous Close:

$16.27

Open:

$16.37

24h Volume:

2.34M

Relative Volume:

1.26

Market Cap:

$1.84B

Revenue:

Net Income/Loss:

$-284.08M

P/E Ratio:

-9.1011

EPS:

-1.78

Net Cash Flow:

$-234.65M

1W Performance:

+1.89%

1M Performance:

+27.96%

6M Performance:

+280.28%

1Y Performance:

+44.00%

1-Day Range:

$16.18

$16.99

1-Week Range:

$15.26

$16.99

52-Week Range:

$3.72

$16.99

Cogent Biosciences Inc Stock (COGT) Company Profile

Name

Cogent Biosciences Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

617-945-5576

Address

275 WYMAN STREET, WALTHAM

Employee

205

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

COGT's Discussions on Twitter

Compare COGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COGT Cogent Biosciences Inc	16.20	2.27B	0	-284.08M	-234.65M	-1.78
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-25	Initiated	Raymond James	Strong Buy
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-11-24	Downgrade	Needham	Buy → Hold
Feb-26-24	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-08-24	Initiated	Citigroup	Buy
Dec-11-23	Downgrade	Wedbush	Outperform → Neutral
Dec-08-23	Initiated	JP Morgan	Overweight
Apr-28-23	Initiated	Robert W. Baird	Outperform
Mar-27-23	Resumed	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Jun-28-22	Initiated	Guggenheim	Buy
Oct-11-21	Initiated	H.C. Wainwright	Buy
Jun-09-21	Resumed	Jefferies	Buy
Dec-23-20	Initiated	Piper Sandler	Overweight
Oct-14-20	Initiated	Ladenburg Thalmann	Buy

View All

Cogent Biosciences Inc Stock (COGT) Latest News

11:10 AM

Momentum divergence signals in Cogent Biosciences Inc. chartJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com

11:10 AM

10:24 AM

Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results - FinancialContent

10:24 AM

10:23 AM

Cogent Biosciences (NASDAQ:COGT) Reaches New 1-Year HighWhat's Next? - MarketBeat

10:23 AM

09:37 AM

Cogent Biosciences stock hits 52-week high at 16.49 USD - Investing.com

09:37 AM

05:32 AM

Will Cogent Biosciences Inc. stock outperform tech sector in 2025Weekly Earnings Recap & Verified Momentum Stock Alerts - newser.com

05:32 AM

04:52 AM

Volume spikes in Cogent Biosciences Inc. stock – what they meanJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com

04:52 AM

Oct 12, 2025

Will Cogent Biosciences Inc. stock split attract more investorsJuly 2025 Outlook & Intraday High Probability Setup Alerts - newser.com

Oct 12, 2025

Oct 10, 2025

Sentiment analysis tools applied to Cogent Biosciences Inc.Trade Volume Report & Real-Time Buy Zone Alerts - newser.com

Oct 10, 2025

Will earnings trigger a reversal in Cogent Biosciences Inc.Dividend Hike & Stepwise Swing Trade Plans - newser.com

Oct 10, 2025

Visual trend scoring systems applied to Cogent Biosciences Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com

Oct 10, 2025

Oct 09, 2025

Cogent Biosciences (NASDAQ:COGT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Cogent Biosciences Inc. stock outlook for YEARJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com

Oct 09, 2025

Oct 06, 2025

Cogent Biosciences (NASDAQ:COGT) Hits New 52-Week HighHere's Why - MarketBeat

Oct 06, 2025

Historical volatility pattern of Cogent Biosciences Inc. visualizedEarnings Risk Report & High Yield Stock Recommendations - newser.com

Oct 06, 2025

Is Cogent Biosciences Inc a good long term investmentEx-Dividend Date Alerts & Rapid Wealth Accumulation - earlytimes.in

Oct 06, 2025

Oct 05, 2025

Published on: 2025-10-05 05:47:04 - newser.com

Oct 05, 2025

When is the best time to exit Cogent Biosciences Inc.CEO Change & Daily Entry Point Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Is Cogent Biosciences Inc. building a consolidation basePortfolio Return Report & Precise Trade Entry Recommendations - newser.com

Oct 03, 2025